Diana Harshbarger Bio
Diana Lynn Harshbarger (born January 1, 1960) is an American pharmacist, businesswoman, and politician serving as the U.S. representative for Tennessee’s 1st congressional district since 2021. A Republican from northeastern Tennessee, she represents a district based in the Tri-Cities area and is the only woman in Tennessee’s current House delegation. She is also a member of the conservative Freedom Caucus and the Republican Study Committee.
Before entering Congress, Harshbarger built a career in pharmacy and healthcare, co-operating a compounding pharmacy with her husband. Focused on issues such as the opioid crisis, religious freedom, anti-abortion legislation, and reducing American dependence on foreign pharmaceutical imports, she first won her seat in 2020 and has since won reelection in 2022 and 2024.
Early Life and Background
Diana Lynn Harshbarger was born in Kingsport, Tennessee, and raised in nearby Bloomingdale. Her upbringing in the Tri-Cities region of northeastern Tennessee shaped her later focus on local healthcare and economic concerns. She is the first person in her family to graduate from high school, an achievement that reflected her determination to pursue higher education and a professional career.
Her early life exposed her to the values of hard work and community service common in her region. These formative experiences influenced her later decision to enter the pharmaceutical profession and, eventually, politics, where she has consistently emphasized faith-based and conservative principles.
Path to US Politics
Harshbarger attended East Tennessee State University, where she earned her Bachelor of Science degree. She then completed her Doctor of Pharmacy at Mercer University, becoming a licensed pharmacist in 1987. With her husband, Bob, she co-operates Premier Pharmacy, a compounding pharmacy serving the local community.
Her professional experience in pharmacy informed her later political priorities, including addressing the opioid crisis, advocating anti-abortion legislation, and protecting religious freedom. She also raised concerns about American dependence on Chinese pharmaceutical imports, framing the issue as one of national security. These positions helped lay the groundwork for her eventual run for Congress.
Early Career (1987-2020)
After earning her pharmacy credentials, Harshbarger spent more than three decades working as a licensed pharmacist in Tennessee. She and her husband built Premier Pharmacy into a well-known compounding pharmacy in the region. Her work gave her direct insight into the challenges facing patients, including concerns about drug pricing, supply chains, and the opioid epidemic.
Her long career in healthcare established her as a respected community figure. By 2020, after six-term incumbent Phil Roe announced his retirement, Harshbarger was well-positioned to enter the race for Tennessee’s 1st congressional district, a seat that has been in Republican hands for all but four years since 1861.
2020 Congressional Election Breakthrough
Harshbarger announced her candidacy to succeed Phil Roe in Tennessee’s 1st congressional district. In a crowded Republican primary on August 5, 2020, she won a 17-way contest and went on to defeat Democratic nominee Blair Walsingham in the November general election. Her primary victory effectively clinched the seat, given the district’s long Republican history.
When she took office on January 3, 2021, she became the fifth woman elected to Congress from Tennessee and only the third who was not standing in for her husband. The district’s strong Republican lean and tradition of long tenures meant Harshbarger became only the ninth person to hold the seat in 100 years.
Reelection and Congressional Tenure (2021-Present)
Since entering Congress, Harshbarger has been an active participant in conservative legislative efforts. She joined 139 other Republican House members in voting to sustain objections to the certification of the 2020 presidential election results. She also co-sponsored resolutions led by Marjorie Taylor Greene to impeach President Joe Biden, Attorney General Merrick Garland, FBI Director Christopher Wray, Secretary of Homeland Security Alejandro Mayorkas, and U.S. Attorney for D.C. Matthew Graves.
In 2023, she was among the 71 Republicans who voted against the Fiscal Responsibility Act. The following year, she voted against a $60 billion military aid package for Ukraine. She has spoken against expanded coverage of anti-obesity drugs for Medicaid and Medicare recipients and has publicly supported President Donald Trump’s policy initiatives, including his 2025 proposal regarding the Gaza Strip. A 2021 Business Insider report also noted that she had been reported for violating the STOCK Act of 2012 by failing to properly disclose more than 700 stock trades.
Notable Events and Milestones
Harshbarger has achieved several notable milestones, including becoming the only woman in Tennessee’s House delegation and the fifth woman elected to Congress from the state. She has won three consecutive congressional elections in 2020, 2022, and 2024, and has been a vocal member of the House Freedom Caucus. Her work has consistently focused on healthcare policy, religious freedom, and conservative legislative priorities.
Diana Harshbarger Family
Family Background and Personal Life
Diana Harshbarger is married to Bob Harshbarger, with whom she co-operates Premier Pharmacy. She is a Baptist, and her faith has played a central role in her public life and policy positions. Her husband previously pleaded guilty to federal charges of distributing misbranded drugs from China to kidney-dialysis patients and was sentenced to 4 years in prison, ordered to pay restitution of $848,504 and a $25,000 criminal fine, and forfeited $425,000 in cash.
The couple has one son, Bobby Harshbarger, who currently serves as the Republican state senator for Tennessee’s 4th Senate district. In July 2024, her husband was issued a summons after being found trying to remove campaign signs from state Senator Jon Lundberg, Bobby’s primary opponent, though all charges against him were later dismissed in August 2024.